Introducing fibril-assembling capability transformed dL5 into a module through which in vivo applications can be developed. The self-assembling system of proteins can be formulated as injectable to render local disposition of therapeutic antibodies. Fluorescence generated from the MG-dL5 binding allows monitoring the physical integrity of the system.
展开▼